Agilysys Inc vs Pfizer Inc — how do they compare? Agilysys Inc trades at $106.05 (market cap $3.00B), while Pfizer Inc trades at $26.5 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 50.6× Agilysys Inc's market cap, and Pfizer Inc pays a 6.46% dividend while Agilysys Inc pays none. Which is the better fit depends on your goals.
| AGYS | PFE | |
|---|---|---|
Market Cap | $3.00B | $151.73B |
Sector | Technology | Health |
52-Week High | $141.12 | $28.56 |
52-Week Low | $62.19 | $23.60 |
Enterprise Value | $2.90B | $203.22B |
Volume | — | 29,869,932 |
Dividend Yield | — | 6.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Trailing returns across standard periods
Latest headlines on both assets
Agilysys provides enterprise software and SaaS solutions for the hospitality industry. Its products specialize in point-of-sale, property management, and inventory systems for hotels, resorts, and cruise lines.
Read more on AGYS →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →